Virus Neutralizing Activity Monoclonal Antibodies Against Epitopes E1 E2 E1
Anti-EpCAM Antibody [3-E1-E2] |
|||
| EM1111 | HUABIO | 100ul | EUR 210 |
|
Description: Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein mediating Ca2+-independent homotypic cell-cell adhesion in epithelia. EpCAM is also involved in cell signaling, migration, proliferation, and differentiation. Additionally, EpCAM has oncogenic potential via its capacity to upregulate c-myc, e-fabp, and cyclins A & E. Since EpCAM is expressed exclusively in epithelia and epithelial-derived neoplasms, EpCAM can be used as diagnostic marker for various cancers. It appears to play a role in tumorigenesis and metastasis of carcinomas, so it can also act as a potential prognostic marker and as a potential target for immunotherapeutic strategies. Mutations in EpCAM have also been associated with congenital tufting enteropathy which causes intractable diarrhea in newborn children. |
|||
Human IgG antibody Laboratories manufactures the virus neutralizing activity monoclonal antibodies against epitopes e1 e2 e1 reagents distributed by Genprice. The Virus Neutralizing Activity Monoclonal Antibodies Against Epitopes E1 E2 E1 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus monoclonal. Other Virus products are available in stock. Specificity: Virus Category: Neutralizing Group: Activity Monoclonal
Cyclin E1 (Cyclin E1) Antibody |
||
| Abbexa |
|
|
Cyclin E1 (Cyclin E1) Antibody |
||
| Abbexa | 100 ug | EUR 577.2 |
human anti-Chikungunya Virus E1 IgG |
||
| EnoGene | 50ug | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
||
Chikungunya E1-E2 Wild Type Protein |
||
| Abbexa | 100 ug | EUR 661.2 |
Chikungunya E1 E2 Composite Antigen (E.coli) |
||
| Creative Diagnostics | 1 mg | EUR 3061.2 |
Recombinant Rubella Virus E1+E2 Protein |
||
| Creative Diagnostics | 1 mg | EUR 1900 |
|
Description: Recombinant |
||
Mayaro Virus VLP (E1; E2; Caspid) |
||
| Creative BioMart | Each | EUR 2162.3 |
|
Description: VLP |
||
Activity Monoclonal information
Human Monoclonal anti-Influenza A hemeagglutinin (HA stem loop) IgG1 (neutralizing for H1N1, H5N1, H6N1, H9N2 etc) |
|||
| H1N14-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Human monoclonal anti-Influenza A hemeagglutinin (HA) IgG (IgG1, recombinant HEK cells, >95%) (Pan antibody, neutralizing for H1, H2, H5, H6, H8, H9 etc) |
|||
| H1N13-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Goat Anti-Human Respiratory Syncytial Virus (RSV) IgG, neutralizing |
|||
| RSV12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| 245-A | Virogen | 1 MG | EUR 850 |
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| 245-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| 247-A | Virogen | 1 MG | EUR 850 |
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| 247-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| MBS485017-01mg | MyBiosource | 0.1mg | EUR 300 |
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| MBS485017-1mg | MyBiosource | 1mg | EUR 1300 |
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| MBS485017-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| MBS485035-01mg | MyBiosource | 0.1mg | EUR 300 |
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| MBS485035-1mg | MyBiosource | 1mg | EUR 1300 |
anti-HCV NS4B IgG2b (monoclonal) Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| MBS485035-5x1mg | MyBiosource | 5x1mg | EUR 5795 |
Rabbit Anti-Poliomyelitis Virus 1 (LSc,2ab strain) antiserum, neutralizing |
|||
| POLV16-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Human respiratory syncytial virus (RSV) Fusion glycoprotein/RSV-F Neutralizing Antibody |
|||
| MBS8104701-02mg | MyBiosource | 0.2mg | EUR 325 |
Human respiratory syncytial virus (RSV) Fusion glycoprotein/RSV-F Neutralizing Antibody |
|||
| MBS8104701-05mg | MyBiosource | 0.5mg | EUR 455 |
Human respiratory syncytial virus (RSV) Fusion glycoprotein/RSV-F Neutralizing Antibody |
|||
| MBS8104701-5x05mg | MyBiosource | 5x0.5mg | EUR 1895 |